160 related articles for article (PubMed ID: 35689468)
1. PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Hoeijmakers YM; Simons M; Bulten J; Gorris MAJ; Ottevanger PB; de Vries IJM; Sweep FCGJ
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):1007-1016. PubMed ID: 35689468
[TBL] [Abstract][Full Text] [Related]
2. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer.
Rimm DL; Han G; Taube JM; Yi ES; Bridge JA; Flieder DB; Homer R; West WW; Wu H; Roden AC; Fujimoto J; Yu H; Anders R; Kowalewski A; Rivard C; Rehman J; Batenchuk C; Burns V; Hirsch FR; Wistuba II
JAMA Oncol; 2017 Aug; 3(8):1051-1058. PubMed ID: 28278348
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.
Veras E; Kurman RJ; Wang TL; Shih IM
Int J Gynecol Pathol; 2017 Mar; 36(2):146-153. PubMed ID: 27362903
[TBL] [Abstract][Full Text] [Related]
4. PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia.
Zong L; Zhang M; Wang W; Wan X; Yang J; Xiang Y
Histopathology; 2019 Sep; 75(3):421-430. PubMed ID: 31013360
[TBL] [Abstract][Full Text] [Related]
5. Analysis of PD-L1 expression in trophoblastic tissues and tumors.
Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y
Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966
[TBL] [Abstract][Full Text] [Related]
6. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes.
Bolze PA; Patrier S; Massardier J; Hajri T; Abbas F; Schott AM; Allias F; Devouassoux-Shisheboran M; Freyer G; Golfier F; You B
Int J Gynecol Cancer; 2017 Mar; 27(3):554-561. PubMed ID: 28060141
[TBL] [Abstract][Full Text] [Related]
8. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
9. Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma.
Downes MR; Slodkowska E; Katabi N; Jungbluth AA; Xu B
Histopathology; 2020 Jan; 76(2):191-200. PubMed ID: 31243779
[TBL] [Abstract][Full Text] [Related]
10. Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies.
Lawson NL; Dix CI; Scorer PW; Stubbs CJ; Wong E; Hutchinson L; McCall EJ; Schimpl M; DeVries E; Walker J; Williams GH; Hunt J; Barker C
Mod Pathol; 2020 Apr; 33(4):518-530. PubMed ID: 31558782
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
12. RUSSCO-RSP comparative study of immunohistochemistry diagnostic assays for PD-L1 expression in urothelial bladder cancer.
Zavalishina L; Tsimafeyeu I; Povilaitite P; Raskin G; Andreeva Y; Petrov A; Kharitonova E; Rumyantsev A; Pugach I; Frank G; Tjulandin S
Virchows Arch; 2018 Dec; 473(6):719-724. PubMed ID: 30209552
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase expression in gestational trophoblastic diseases.
Barut A; Harma M; Arikan I; Harma MI; Barut F
Int J Gynecol Cancer; 2010 Apr; 20(3):337-40. PubMed ID: 20375793
[TBL] [Abstract][Full Text] [Related]
14. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
15. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
16. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
[TBL] [Abstract][Full Text] [Related]
17. High concordance of programmed death-ligand 1 expression with immunohistochemistry detection between antibody clones 22C3 and E1L3N in non-small cell lung cancer biopsy samples.
Zhang W; Cao Z; Gao C; Huang Y; Wu C; Zhang L; Hou L
Transl Cancer Res; 2020 Oct; 9(10):5819-5828. PubMed ID: 35117196
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients.
Schmidt G; Guhl MM; Solomayer EF; Wagenpfeil G; Hammadeh ME; Juhasz-Boess I; Endrikat J; Kasoha M; Bohle RM
Arch Gynecol Obstet; 2022 Nov; 306(5):1689-1695. PubMed ID: 35377046
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases.
Marzioni D; Quaranta A; Lorenzi T; Morroni M; Crescimanno C; De Nictolis M; Toti P; Muzzonigro G; Baldi A; De Luca A; Castellucci M
Histol Histopathol; 2009 Oct; 24(10):1213-22. PubMed ID: 19688690
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays.
Munari E; Zamboni G; Lunardi G; Marconi M; Brunelli M; Martignoni G; Netto GJ; Quatrini L; Vacca P; Moretta L; Bogina G
Hum Pathol; 2019 Aug; 90():54-59. PubMed ID: 31121194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
